Macrophage polarization-regulating pathways

Macrophage polarization-regulating pathways are the complex signaling networks that control the functional plasticity of macrophages, allowing them to adapt to diverse physiological and pathological environments. These pathways dictate the transition between the classically activated M1 phenotype, which is pro-inflammatory and anti-tumor, and the alternatively activated M2 phenotype, which is anti-inflammatory and promotes tissue repair (PMID: 28438288). Key molecular drivers include the JAK/STAT, NF-κB, PI3K/Akt, and MAPK signaling cascades, which are activated by various cytokines and microbial products (PMID: 30619121). In many diseases, particularly cancer, these pathways are dysregulated; tumor-associated macrophages (TAMs) are often polarized toward an M2-like state that suppresses anti-tumor immunity and promotes metastasis (PMID: 31067412). Therapeutic strategies focus on 're-educating' these cells by targeting specific pathway components, such as CSF1R or TLRs, to restore a pro-inflammatory, anti-tumor environment. Consequently, these pathways represent a critical frontier in immunotherapy for cancer, fibrosis, and chronic inflammatory disorders.

Other names

Macrophage polarizationM1/M2 polarizationMacrophage activation pathwaysTAM reprogrammingMacrophage phenotypic switching

Pharmacological modulation of macrophage polarization involves the inhibition or activation of specific signaling nodes, such as CSF1R, JAK/STAT, or TLRs, to shift the balance between pro-inflammatory (M1) and anti-inflammatory (M2) functional states.